0
0
0
s2smodern

Harry Shapiro Director DrugWise

Having done a brief round-up of 2016 in my first column, this week's column is a catch-up on the news so far in 2017.

Previously I mentioned the harm reduction battle cross-over between drugs and e-cigarettes: reports in the news this year highlight another connection – how scientists, clinicians and the media can mislead the general public.

0
0
0
s2smodern

Harry Shapiro Director DrugWise

Welcome to my new column brought to you by Nicotine Science and Policy. The idea is that I provide a summary and commentary of the weeks' news and events for those who have not had the time to check out the NSP News Digest on a daily basis or missed an important news item from elsewhere.